PARI is the clinical choice, make us your choice.

PARI products are used in more clinical trials to prove safety and efficacy of new medications compared to any other brand. PARI continues to innovate by offering novel marketing solutions for product launches and promotions. These programs are designed to meet the unique needs of pharmaceutical companies from early experimental phases to commercialization.

PARI’s expertise in aerosol science, superior device performance and proven track record with clinical trials provides pharmaceutical companies with innovative and effective solutions for inhaled drug delivery.

In addition, PARI products are currently being used in numerous clinical trials for new medications delivered by nebulizer. PARI is a proven partner with the following pharmaceutical companies; our products are listed in the package insert for many medications including those indicated (*) below:

  • Pulmozyme® for cystic fibrosis*
  • Pulmicort Respules® for asthma*
  • TOBI® for cystic fibrosis*
  • DuoNeb® for COPD, asthma*
  • AccuNeb® for asthma*
  • Perforomist® for COPD*
  • Xopenex® for asthma*
  • Brovana® (arfomoterol tartate) for COPD*
  • Cayston® (Aztreonam lysine) for cystic fibrosis

* All registered marks and trademarks belong to their respective companies.

To contact PARI about clinical trials, research, or pharmaceutical marketing opportunities call 1.800.FAST. NEB

Contact us

Any questions? You can reach a customer service representative at:
or 1-800-FAST-NEB (327-8632)

International Distribution Partners

If you are looking to buy PARI products in a specific country, please click here